News
An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...
A study published in Med has found that the HIV medication lamivudine significantly improved visual acuity in adults with ...
7d
HealthDay on MSNLamivudine Improves Visual Acuity in Center-Involved Diabetic Macular EdemaFor patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a study ...
On the basis of the Medicare allowable charges, the approximate cost for a single intravitreous injection is $1,950 for aflibercept (at a dose of 2.0 mg), $50 for bevacizumab (under the assumption ...
KOLOA, Hawaii — Having a standard method of communication in place for staff helps prevent wrong intravitreous injections, according to a speaker here. During a Retina 2023 presentation ...
Intravitreous injections of anti-VEGF agents may increase the risk of elevated intraocular pressure (IOP); however, the risk of developing moderate to advanced glaucoma requiring glaucoma surgery ...
CHICAGO — Topical antibiotic prophylaxis is completely unnecessary in association with intravitreal injections, according to findings from more than 15,000 injections by a single surgeon who ...
Individual eyes were randomly assigned to receive PRP treatment, completed in 1 to 3 visits (n = 203 eyes), or the anti-VEGF agent ranibizumab, by intravitreous injection at study entry and as ...
Patients with one study eye (i.e., with one eye involved in the trial) were randomly assigned in a 1:1 ratio to receive either 2.0 mg of intravitreous ... six monthly injections were administered ...
The advent of intravitreous (in the vitreous, the fluid behind the lens in the eye) anti-vascular endothelial growth factor (VEGF) injections to treat common causes of vision loss, such as ...
Individual eyes were randomly assigned to receive PRP treatment, completed in 1 to 3 visits (n = 203 eyes), or the anti-VEGF agent ranibizumab, by intravitreous injection at study entry and as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results